NexturnBioscience Co. Ltd (089140) — Cash Flow Quality Index
NexturnBioscience Co. Ltd (089140) has a Cash Flow Quality Index of 11.02x as of September 2025. Operating cash flow of ₩4.51 Billion exceeds net income of ₩409.51 Million, indicating high earnings quality where cash backs reported profits. Explore NexturnBioscience Co. Ltd (089140) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NexturnBioscience Co. Ltd Cash Flow Quality Index (2007–2023)
Historical Cash Flow Quality Index for NexturnBioscience Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 089140 cash flow metrics.
Annual Cash Flow Quality Index for NexturnBioscience Co. Ltd (2007–2023)
Year-by-year earnings quality comparison for NexturnBioscience Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.20x | ₩-1.97 Billion | ₩9.68 Billion | ▼ -142.8% |
| 2019 | 0.48x | ₩2.74 Billion | ₩5.76 Billion | ▼ -72.6% |
| 2018 | 1.73x | ₩9.63 Billion | ₩5.55 Billion | ▲ +131.4% |
| 2017 | 0.75x | ₩5.08 Billion | ₩6.78 Billion | ▼ -7.5% |
| 2016 | 0.81x | ₩17.88 Billion | ₩22.05 Billion | ▼ -42.4% |
| 2015 | 1.41x | ₩1.92 Billion | ₩1.36 Billion | ▼ -11.4% |
| 2014 | 1.59x | ₩6.48 Billion | ₩4.08 Billion | ▲ +1584.5% |
| 2010 | 0.09x | ₩235.94 Million | ₩2.50 Billion | ▼ -89.6% |
| 2009 | 0.91x | ₩998.03 Million | ₩1.10 Billion | ▲ +98.4% |
| 2008 | 0.46x | ₩945.34 Million | ₩2.06 Billion | ▼ -45.0% |
| 2007 | 0.83x | ₩2.26 Billion | ₩2.71 Billion | — |